Zobrazeno 1 - 10
of 231
pro vyhledávání: '"TRIDENTE, GIUSEPPE"'
Publikováno v:
In Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders 2023:403-573
Autor:
Ahmad, Suhana, Alkalamouni, Habib, Ashraf, Ghulam Md, Azfal, Asia, Bali, Anjana, Batool, Zehra, Choubey, Shruti Shikha, Dakroub, Fatima, Dakroub, Rayan, Deng, Yi, El Orfali, Youmna, El-Khatib, Aiman S., Faiz Ghalib, Asad Ullah, Fu, Leilei, Gautam, Avtar Singh, Haider, Saida, Hassan, Md. Imtaiyaz, Inamullah, Aimen, Jaggi, Amteshwar Singh, Jana, Ankit, Kobeissy, Firas, Kong, Hesheng, Kong, Eryan, Kumar, Dhiraj, Lambuk, Lidawani, Liaquat, Laraib, Li, Wenqiang, Liu, Bo, Mansour, Heba M., Mantash, Sara, Mohamud, Rohimah, Mohd Lazaldin, Mohd Aizuddin, Nath, Arnab, Nisar, Rida, Numakawa, Tadahiro, Odaka, Haruki, Pandey, Shivam Kumar, Pulivarthi, Chinna Babu, Randhawa, Puneet Kaur, Sadir, Sadia, Singh, Rakesh Kumar, Su, Xi, Tridente, Giuseppe, Yan, Peipei, Zhang, Yichi
Publikováno v:
In Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders 2023:xi-xiii
Autor:
Guerriero, Chiara, Zoccatelli, Gianni, Stefani, Elisabetta, Sartoris, Silvia, Cestari, Tiziana, Riviera, Anna Pia, Tridente, Giuseppe, Andrighetto, Giancarlo, Chignola, Roberto *
Publikováno v:
In Journal of Neuroimmunology 2003 141(1):83-89
Autor:
Solero Pietro, De Gironcoli Marzia, Ortolani Riccardo, Vella Antonio, Chirumbolo Salvatore, Tridente Giuseppe, Bellavite Paolo
Publikováno v:
Clinical and Molecular Allergy, Vol 6, Iss 1, p 12 (2008)
Abstract Background Basophils are circulating cells involved in hypersensitivity reactions and allergy but many aspects of their activation, including the sensitivity to external triggering factors and the molecular aspects of cell responses, are sti
Externí odkaz:
https://doaj.org/article/b60ef743ca6e4df4a27367d3118c0aa3
Autor:
Candiani, Carola, Tommasi, Marina, Fracasso, Giulio, Lorenzetti, Irene, Adami, Alessandra, Benoni, Giuseppina, Tridente, Giuseppe, Colombatti, Marco *
Publikováno v:
In Life Sciences 2001 69(3):335-346
Autor:
Sartoris, Silvia *, Brendolan, Andrea, Degola, Alexa, Testi, Maria Grazia, Chignola, Roberto, Scarpa, Aldo, Scardoni, Maria, Contreas, Giovanna, Pinelli, Leonardo, Lunardi, Claudio, Beri, Ruggero, Pera, Cinzia, Ferrara, G.Battista, Riviera, Anna Pia, Tridente, Giuseppe, Andrighetto, Giancarlo
Publikováno v:
In Human Immunology 2000 61(6):599-604
Autor:
Tridente, Giuseppe
Publikováno v:
Adverse Events with Biomedicines
Rituximab (Rituxan®, MabThera®, and Genentech/Roche) is a chimeric murine/human monoclonal IgG1k antibody directed against the CD20 antigen located at the surface of normal and malignant B lymphocytes. Electronic supplementary material The online v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmc_________::9c2cd1ea1723106961798698f937dda7
http://europepmc.org/articles/PMC7121599
http://europepmc.org/articles/PMC7121599
Autor:
Tridente, Giuseppe
Publikováno v:
Adverse Events with Biomedicines
Since the introduction of biomedicines in human therapy, a number of systemic reactions have been more frequently reported as important adverse events following treatment. Some monoclonal antibodies, interleukins, receptor inhibitors, and growth fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmc_________::0ca2c6b7a928eb1bd5df1ba306e81091
http://europepmc.org/articles/PMC7121214
http://europepmc.org/articles/PMC7121214
Autor:
Tridente, Giuseppe
Publikováno v:
Adverse Events with Biomedicines
Alemtuzumab (Campath®, MabCampath®, Genzyme) is an IgG1k anti-CD52 humanized monoclonal antibody (mAb) that was first licensed in March 2001 by FDA. EMEA granted its approval in July 2001 and Health Canada in November 2005. The initial indication w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmc_________::c7570d0a6bdef68ed523924ce6cfeac6
http://europepmc.org/articles/PMC7122495
http://europepmc.org/articles/PMC7122495
Autor:
Tridente, Giuseppe
Publikováno v:
Adverse Events with Biomedicines
Biomedicines are new agents with old roots. Products of biological origin, such as vaccines, blood and serum components, human proteins, hormones, and immunoglobulins, are used from long time in human therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmc_________::8b116a420199856ffb7357b507cb2b7d
http://europepmc.org/articles/PMC7121039
http://europepmc.org/articles/PMC7121039